QVT Financial’s Traws Pharma TRAW Stock Holding History

QVT Financial’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-2	Closed	-$2.49M	–	84
2013 Q3	$2.49M	Buy	+2	New	+$2.86M	0.17%	64

Other funds holding TRAW

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

Weatherbie Capital Boston, Massachusetts $797M AUM 23.31% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

QVT Financial's TRAW Position: Q4 2013 in Review

QVT Financial sold out of Traws Pharma (TRAW) in Q4 2013, closing a stake of 2 shares — an estimated $2.49M sold.

QVT Financial first reported a position in TRAW in Q3 2013 and held it in 1 quarter. The position peaked at $2.49M in Q3 2013. 17 funds tracked by Wall St. Rank hold TRAW as of Q4 2013.

QVT Financial reported no remaining Traws Pharma position as of Q4 2013 after selling out during the quarter.
QVT Financial sold 2 Traws Pharma shares in Q4 2013, an estimated $2.49M.
QVT Financial first reported a position in Traws Pharma in Q3 2013 and held it in 1 quarter.
QVT Financial's Traws Pharma position peaked at $2.49M in Q3 2013.
17 funds tracked by Wall St. Rank held Traws Pharma as of Q4 2013.

Based on QVT Financial's 13F filing for Q4 2013, filed 18 Feb 2014.